SHARE-BASED PAYMENT - Summary of warrants and pre-funded warrants activity and related information (Details) - Warrants and Prefunded Warrants - $ / shares |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Weighted Average Exercise Price | ||||
| Outstanding, Beginning Balance | $ 0.08 | $ 0.17 | $ 0.17 | |
| Expired | 0.06 | 0.32 | ||
| Exercised | 0.06 | |||
| Outstanding, Ending Balance | 0.09 | $ 0.08 | $ 0.17 | $ 0.17 |
| Vested and expected to vest | 0.09 | |||
| Exercisable | $ 0.09 | |||
| Weighted average remaining contractual life | ||||
| Outstanding | 1 year 6 months 21 days | 1 year 9 months 3 days | 2 years 25 days | 3 years 25 days |
| Exercised | 2 months 1 day | |||
| Vested and expected to vest | 1 year 6 months 21 days | |||
| Exercisable | 1 year 6 months 21 days | |||
| Common Class A | ||||
| Number of options | ||||
| Outstanding, Beginning balance | 470,833,300 | 731,333,300 | 731,333,300 | |
| Expired | (155,166,650) | (260,000,000) | ||
| Exercised | (500,000) | |||
| Outstanding, Ending balance | 315,666,850 | 470,833,300 | 731,333,300 | 731,333,300 |
| Vested and expected to vest | 315,666,850 | |||
| Exercisable | 315,666,850 | |||
| X | ||||||||||
- Definition The number of shares into which fully or partially vested other than stock options outstanding as of the balance sheet date can be currently converted under the other than stock option plan. No definition available.
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of other than options outstanding and currently exercisable under the other than stock option plan. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for exercisable equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that exercised during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price as of the grant date of equity-based award plans other than stock (unit) option plans that were exercised or put into effect as a result of the occurrence of a terminating event. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for exercised equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were expired during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. No definition available.
|
| X | ||||||||||
- Definition N/A No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average exercise price nonvested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Number of fully vested and expected to vest equity instruments other than options outstanding that can be converted into shares under other than option plan. No definition available.
|
| X | ||||||||||
- Definition Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest equity instruments other than options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested and expected to vest equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Sharebased Compensation Arrangement By Sharebased Payment Award, NonOptions Outstanding, Weighted Average Remaining Contractual Term [Abstract]. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|